Fiducial markers are used in image-guided procedures that are mostly performed by radiologists (interventional) for preparation of several types of radiation therapies. These therapies include stereotactic body radiotherapy (SBRT), stereotactic radio-surgery (SRS), or proton therapy. These markers are tiny metal, normally made of gold spheres, cylinders, or coils of a grain size of rice. They are placed near or in the tumor for guiding the fixing of radiation beams while treatment. Fiducial markers are generally used to define the target abrasion located in the soft tissues of chest, including the chest and lung wall, pelvis comprising the prostrate, abdomen, including gallbladder, pancreas, kidney, and the liver, and neck and the head. These markers help the physicians to target the tumor with optimal accuracy and enable the treatment to be delivered with maximum dose while cautious healthy tissues.
Fiducial Markers Market is anticipated to grow at a CAGR of 4.3% from 2020 to 2030.
There is an increased demand for radiation therapy owing to the rising cancer cases, especially in the geriatric population. Most healthcare settings that perform several radiology tests on patients claim that these patients require frequent hospital visits with increased risk of being suspected and affected with Coronavirus. Hence, with the ongoing pandemic of COVID-19, FDA has recently approved one 15-minute test that has proved its efficiency in testing several patients with reduced hospital visits. This test is of utmost benefit to the radiation oncology department that allows patients to be tested during simulation.
Get Access To Sample Pages:
Major Key Players:CIVCO Radiotherapy, Boston Scientific Corporation, IZI Medical Products, IBA Worldwide, Naslund Medical Inc., Medtronic, Best Medical International, Inc., Nanovi A/S, Eckert & Ziegler., Innovative Oncology Solutions, and others.
Fiducial Markers Market By Product:
Polymer-Based Markers and Metal-Based Markers:Gold Combination Markers and Pure Gold Markers
MRI, Radiotherapy, Ultrasound and CT/CBCT
By Cancer Type:
Breast Cancer, Lung Cancer, Prostate Cancer, and Gastric Cancer
By End User:
Cancer Research Centers, Hospitals & Outpatient Facilities, and Independent Radiotherapy Centers
Key Findings In Fiducial Markers Market Report:
-To break down and inspect the worldwide Fiducial Markers status and future figure including, creation, income, utilization, recorded and conjecture.
– To introduce the key Fiducial Markers makers, creation, income, piece of the pie, SWOT examination and improvement designs in next barely any years.
– To section the breakdown information by areas, type, producers and applications.
– To break down the worldwide and key areas advertise potential and preferred position, opportunity and challenge, restrictions and dangers.
– To distinguish noteworthy patterns, drivers, impact factors in worldwide and districts.
– To deliberately investigate each submarket regarding singular development pattern and their commitment to the market.
– To break down serious advancements, for example, developments, understandings, new item dispatches, and acquisitions in the market.
Table of Content
1 Introduction of Fiducial Markers Market
1.1 Overview of the Market
1.2 Scope of Report
2 Executive Summary
3 Research Methodology of Market Industry Reports
3.1 Data Mining
3.3 Primary Interviews
3.4 List of Data Sources
4 Fiducial Markers Market Outlook
4.2 Market Dynamics
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Fiducial Markers Market, By Deployment Model
6 Fiducial Markers Market, By Solution
7 Fiducial Markers Market, By Vertical
8 Fiducial Markers Market, By Geography
8.1 North America
8.3 Asia –Pacific
8.4 Rest of world
For Deep Analysis Of Covid-19 Impact:
About Market Industry Reports
Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the calibre of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
|2nd Floor, Manikchand Ikon,|
|B-Wing, Dhole Patil Road,|
|Sangamwadi, Pune 411 001|
|Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK )|